Sven Wehrwein
CIK: 0001205069
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jul 28, 2026ATRC
AtriCure, Inc.
Sale(S)Direct25K shares at avg. $37.84$946K - Jul 28, 2026ATRC
AtriCure, Inc.
Exercise(M)Direct25K shares at avg. $19.95$499K - Jun 2, 2026PRLB
Proto Labs Inc
Sale(S)Direct500 shares at avg. $78.38$39K - Jun 2, 2026PRLB
Proto Labs Inc
Sale(S)Direct1.5K shares at avg. $76.91$115K - May 19, 2026PRLB
Proto Labs Inc
Award(A)Direct2.2K shares- - May 18, 2026ATRC
AtriCure, Inc.
Award(A)Direct6.1K shares- - Nov 25, 2025ATRC
AtriCure, Inc.
Sale(S)Direct5K shares at avg. $38.00$189K - Nov 25, 2025ATRC
AtriCure, Inc.
Exercise(M)Direct5K shares at avg. $19.95$99K - Nov 24, 2025ATRC
AtriCure, Inc.
Exercise(M)Direct5K shares at avg. $19.95$100K - Nov 24, 2025ATRC
AtriCure, Inc.
Sale(S)Direct5K shares at avg. $37.32$188K - Aug 22, 2025ATRC
AtriCure, Inc.
Sale(S)Direct5K shares at avg. $37.00$185K - Aug 22, 2025ATRC
AtriCure, Inc.
Exercise(M)Direct5K shares at avg. $19.95$100K - Aug 19, 2025ATRC
AtriCure, Inc.
Exercise(M)Direct5K shares at avg. $19.95$100K - Aug 19, 2025ATRC
AtriCure, Inc.
Sale(S)Direct5K shares at avg. $36.00$180K - May 23, 2025PRLB
Proto Labs Inc
Award(A)Direct3.9K shares- - May 19, 2025ATRC
AtriCure, Inc.
Award(A)Direct5.4K shares- - May 13, 2025SPSC
SPS COMMERCE INC
Award(A)Direct1.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 |  ATRC AtriCure, Inc. | Sale(S) | 25,000 | $37.84 | $946,000 | Direct |
| Jul 28, 2026 | ATRC AtriCure, Inc. | Exercise(M) | 25,000 | $19.95 | $498,750 | Direct |
| Jun 2, 2026 |  PRLB Proto Labs Inc | Sale(S) | 500 | $78.38 | $39,190 | Direct |
| Jun 2, 2026 | PRLB Proto Labs Inc | Sale(S) | 1,500 | $76.91 | $115,360 | Direct |
| May 19, 2026 | PRLB Proto Labs Inc | Award(A) | 2,210 | - | $0 | Direct |
| May 18, 2026 | ATRC AtriCure, Inc. | Award(A) | 6,144 | - | $0 | Direct |
| Nov 25, 2025 | ATRC AtriCure, Inc. | Sale(S) | 4,967 | $38.00 | $188,746 | Direct |
| Nov 25, 2025 | ATRC AtriCure, Inc. | Exercise(M) | 4,967 | $19.95 | $99,092 | Direct |
| Nov 24, 2025 | ATRC AtriCure, Inc. | Exercise(M) | 5,033 | $19.95 | $100,408 | Direct |
| Nov 24, 2025 | ATRC AtriCure, Inc. | Sale(S) | 5,033 | $37.32 | $187,832 | Direct |
| Aug 22, 2025 | ATRC AtriCure, Inc. | Sale(S) | 5,000 | $37.00 | $185,000 | Direct |
| Aug 22, 2025 | ATRC AtriCure, Inc. | Exercise(M) | 5,000 | $19.95 | $99,750 | Direct |
| Aug 19, 2025 | ATRC AtriCure, Inc. | Exercise(M) | 5,000 | $19.95 | $99,750 | Direct |
| Aug 19, 2025 | ATRC AtriCure, Inc. | Sale(S) | 5,000 | $36.00 | $180,000 | Direct |
| May 23, 2025 | PRLB Proto Labs Inc | Award(A) | 3,939 | - | - | Direct |
| May 19, 2025 | ATRC AtriCure, Inc. | Award(A) | 5,401 | - | - | Direct |
| May 13, 2025 |  SPSC SPS COMMERCE INC | Award(A) | 1,310 | - | - | Direct |
1-17 of 17 transactions
About WEHRWEIN SVEN
WEHRWEIN SVEN (SEC CIK 0001205069) files insider reports with the SEC as Director of AtriCure, Inc. (ATRC), Director of Proto Labs Inc (PRLB) and Director of SPS COMMERCE INC (SPSC).
Signal8 holds 10 ownership filings by WEHRWEIN SVEN, all Form 4s, filed between May 15, 2025 and Jul 30, 2026. Those filings report 17 transactions, from May 13, 2025 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WEHRWEIN SVEN's filings is in MINNEAPOLIS, MN.
Recent filings by WEHRWEIN SVEN
- Jul 28, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Jul 28, 2026: Option exercise of ATRC shares (Form 4, code M).
- Jun 2, 2026: Open-market sales of PRLB shares (2 lines, Form 4, code S).
- May 19, 2026: Grant or award of PRLB shares (Form 4, code A).
- May 18, 2026: Grant or award of ATRC shares (Form 4, code A).
Other insiders filing for AtriCure, Inc. (ATRC)
- Privitera Salvatore, Chief Technical Officer
- GROVES REGINA E, Director
- Dahlquist Karl S., Chief Legal Officer
- Prange Karen, Director
- Yuen Maggie, Director
- CARREL MICHAEL H, President, CEO, & Director